1. From the Department of Pharmacology and Vascular Biology and Therapeutics Program (C.F.-H., L.J., D.J., A.D.L., W.C.S.), Yale University School of Medicine, New Haven, Conn; and the Departments of Medicine, Leon H. Charney Division of Cardiology, and Cell Biology and the Marc and Ruti Bell Vascular Biology and Disease Program (C.F.-H.), New York University School of Medicine, New York.